Stability LPL II
A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
- Stage
- klaar
- Medicine
- darapladib
- Population
- ASCVD
- Phase
- III
- First Patient In
- 1 January 2009
- Last Patient In
- 2 June 2011
- Last Patient Last Visit
- -
Study Director
